Etoposide induces growth arrest and disrupts androgen receptor signaling in prostate cancer cells

Oncology Reports

Volumn 23, Issue 1, 2010, Pages 165-170

  Liu, Shicheng ^a   Yamauchi, Hitoshi ^a  

^a Nipro Corporation   (Japan)

Author keywords

Androgen receptor; Etoposide; Prostate cancer; Prostate specific antigen

Indexed keywords

ANDROGEN RECEPTOR; ETOPOSIDE; HEAT SHOCK PROTEIN 90; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN LNCAP; CONCENTRATION RESPONSE; DRUG EFFECT; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICROSCOPY, CONFOCAL; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

EID: 76049094102     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000618     Document Type: Article

References (15)

1. Chang CS, Kokontis J and Liao ST: Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240: 324-326, 1988.
2. Rahman M, Miyamoto H and Chang CS: Androgen receptor coregulators in prostate cancer: mechanisms and clinical implications. Clin Cancer Res 10: 2208-2219, 2004.
3. Gobinet J, Poujol N and Sultan C: Molecular action of androgens. Mol Cell Endocrinol 198: 15-24, 2002.
4. Gelmann EP: Molecular biology of the androgen receptor. J Clin Oncol 20: 3001-3015, 2002.
5. Dixon SC, Knopf KB and Figg WD: The control of prostate-specific antigen expression and gene regulation by pharmacological agents. Pharmacol Rev 53: 73-91, 2001.
6. Mizumoto K, Rothman RJ and Farber JL: Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide. Mol Pharmacol 46: 890-895, 1994.
7. Burden AD and Osheroff N: Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim Biophys Acta 1400: 139-154, 1998.
8. Karpinich NO, Tafani M, Rothman RJ, Russo MA and Farber JL: The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J Biol Chem 277: 16547-16552, 2002.
9. Liu S and Yamauchi H: Hinokitiol, a metal chelator derived from natural plants, suppresses cell growth and disrupts androgen receptor signaling in prostate carcinoma cell lines. Biochem Biophys Res Commun 351: 26-32, 2006.
10. Liu S, Mizu H and Yamauchi H: Molecular response to phototoxic stress of UVB-irradiated ketoprofen through arresting cell cycle in G2/M phase and inducing apoptosis. Biochem Biophys Res Commun 364: 650-655, 2007.
11. Retter AS, Gulley JL and Dahut WL: Novel therapeutic strategies in prostate cancer. Cancer Bio1 Ther 3: 371-376, 2004.
12. Wickert L and Selbig J: Structural analysis of the DNA-binding domain of alternatively spliced steroid receptors. J Endocrinol 173: 429-436, 2002.
13. Gray PJ Jr, Stevenson MA and Calderwood SK: Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells. Cancer Res 67: 11942-11950, 2007.
14. Roy AK, Tyagi RK, Song CS, Lavrovski Y, Ahn SC and Chatterjee B: Androgen receptor: structural domains and functional dynamics after ligand-receptor interaction. Ann NY Acad Sci 949: 44-57, 2001.
15. Balk SP, Ko YL and Bubley GJ: Biology of prostate-specific antigen. J Clin Oncol 21: 383-391, 2003.